Neogen Corporation Q4 2025 Earnings Recap

NEOG Q4 2025 August 2, 2025

Get alerts when NEOG reports next quarter

Neogen Corporation's fourth quarter results reflect ongoing challenges in the Food Safety segment, compounded by market and regulatory pressures. However, strategic initiatives in pathogen detection and operational simplification signal a focused path forward.

Earnings Per Share Miss

$0.05 vs $0.08 est.

-37.5% surprise

Revenue Beat

225459000 vs 202666670 est.

+11.2% surprise

Market Reaction

1-Day +0.43%

5-Day +9.01%

30-Day +23.18%

See NEOG alongside your other holdings

Add to your portfolio — free

Key Takeaways

Food Safety end market conditions worsened due to ongoing inflation pressures, leading to lower production volumes among food producers.
Neogen launched the Listeria Right Now assay on its MDS platform, enhancing pathogen detection capabilities.
The Board is transitioning the CEO role to better align with future growth potential amidst a regulatory environment prioritizing food safety.
Core revenue in the Animal Safety segment has faced headwinds, but signs of improvement in net farm incomes could support recovery.
Ongoing divestiture processes aim to streamline operations and prioritize core business areas for improved focus and deleveraging.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit NEOG on AllInvestView.